Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02LWU
|
||||
Former ID |
DAP001549
|
||||
Drug Name |
Pralatrexate
|
||||
Synonyms |
Folotyn (TN)
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Allos Therapeutics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C23H23N7O5
|
||||
InChI |
InChI=1S/C23H23N7O5/c1-2-3-14(10-15-11-26-20-18(27-15)19(24)29-23(25)30-20)12-4-6-13(7-5-12)21(33)28-16(22(34)35)8-9-17(31)32/h1,4-7,11,14,16H,3,8-10H2,(H,28,33)(H,31,32)(H,34,35)(H4,24,25,26,29,30)/t14?,16-/m0/s1
|
||||
InChIKey |
OGSBUKJUDHAQEA-WMCAAGNKSA-N
|
||||
CAS Number |
CAS 146464-95-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
10249810, 14761163, 14907808, 46225076, 47207252, 57346701, 76049103, 99437279, 103771482, 104418267, 124950714, 126666101, 131408688, 134223179, 135692165, 136367814, 137248707, 141792755, 144206459, 144236486, 152106310, 152258219, 152344466, 160646081, 160647055, 164044033, 164232763, 164764489, 175427094, 175437712, 176484650, 178103446, 180191813, 184527271, 186014781, 198993109, 223392464, 223659651, 223702389, 225255488, 226410872, 240035409, 241036657, 243124404, 249868098, 252069088, 252214139, 252473148
|
||||
SuperDrug ATC ID |
L01BA05
|
||||
Target and Pathway | |||||
Target(s) | Dihydrofolate reductase | Target Info | Inhibitor | [530677] | |
PathWhiz Pathway | Folate Metabolism | ||||
Pterine Biosynthesis | |||||
References | |||||
Ref 530677 | Hughes B: 2009 FDA drug approvals. Nat Rev Drug Discov. 2010 Feb;9(2):89-92. | ||||
Ref 541920 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6840). | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.